Skip to Main Content

Paper Details

Histology-agnostic approvals for antibody-drug conjugates in solid tumours: is the time ripe?
Eur J Cancer
8
2022
cancer, malignancies, solid tumours
Author NameAffiliation
Chiara CortiEuropean Institute of Oncology, IRCCS, University of Milan
Lisa A CareyUniversity of North Carolina Lineberger Comprehensive Cancer Center
Carmen CriscitielloEuropean Institute of Oncology, IRCCS, University of Milan
Giuseppe CuriglianoEuropean Institute of Oncology, IRCCS, University of Milan
  • 1 - 4

Datasets

Release 1.2